Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board  >  Cannabis Science Inc    

 SummaryNewsCompany 
Company
Cannabis Science, Inc. develops cannabis pharmaceutical products.The company works on phytocannabinoid science targeting critical illnesses and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products.Cannabis Science was founded by... 
More about the company
Latest news on CANNABIS SCIENCE INC
03/27 CANNABIS SCIENCE : CBIS Ramps Up Production and Releases More New Products to Me..
03/10 CANNABIS SCIENCE : Receives Delivery Notifications for First Greenhouse Orders a..
03/08 CANNABIS SCIENCE : Receives Delivery Notifications for First Greenhouse Orders a..
03/02 CANNABIS SCIENCE : Announces Update on Proposed DPI Inhalation Device, CBD Infus..
03/02 CANNABIS SCIENCE : Senior Executives to Co-Chair Special Session and Deliver a K..
02/24 CANNABIS SCIENCE : Announces Update on Proposed DPI Inhalation Device, CBD Infus..
02/21 CANNABIS SCIENCE : Crown Baus Capital Corp. Acquires 100-Acre Investment Partici..
02/17 CROWN BAUS CAPITAL CORP. : Acquires 100-Acre Investment Participation in Cannabi..
02/01 Marijuana Industry Pushing Toward Federal Acceptance, Expanded Research in 20..
01/25 CANNABIS SCIENCE : Distributors Sells Out of Initial Test Batch of CBIS Metered ..
More news
Sector news : Bio Therapeutic Drugs
03/18DJAMGEN : Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- 3rd Update
03/17DJAMGEN : Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- 2nd Update
03/17DJAMGEN : Money-Back Guarantee
03/17DJAmgen's Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- Update
03/17DJAmgen's Repatha Study Shows Reduced Risk of Heart Attack, Stroke
More sector news : Bio Therapeutic Drugs
Advertisement
Managers
NameTitle
Raymond C. Dabney President, Chief Executive Officer & Director
Robert Kane Chief Operating Officer & Director
Benjamin C. K. Tam Chief Financial Officer, Secretary & Director
Richard Ogden Chief Scientific Officer
Allen A. Herman Chief Medical Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CANNABIS SCIENCE INC0
AMGEN, INC.12.79%121 448
CELGENE CORPORATION7.87%97 137
GILEAD SCIENCES, INC.-5.74%88 227
REGENERON PHARMACEUTIC..4.52%40 701
ACTELION LTD24.40%29 848
More Results